Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Financial Tribune.
Press releases published on June 23, 2025
Brera Holdings Completes Final Closing and Acquires 52 Percent Majority Ownership Stake in Storied Italian Serie B Football Club SS Juve Stabia srl “The Second Team of Naples”
GlobeNewswire
·
June 23, 2025
Juve Stabia Club President Andrea Langella (left) with Brera Holdings PLC Executive Chairman Daniel McClory (right) Dublin, Ireland, and Naples, Italy, June 23, 2025 (GLOBE NEWSWIRE) -- Brera Holdings PLC ("Brera Holdings," “Brera” or the “Company”) ( …
Oportun Issues Letter to Stockholders Detailing CEO Raul Vazquez’s Record of Proven Leadership
GlobeNewswire
·
June 23, 2025
Urges stockholders to vote “FOR” Mr. Vazquez and Carlos Minetti on the GREEN proxy card SAN CARLOS, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Oportun (Nasdaq: OPRT), a mission-driven financial services company, today issued a letter to stockholders …
Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary
GlobeNewswire
·
June 23, 2025
FLORHAM PARK, N.J., June 23, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced the appointment …
Clearmind Medicine Adds Leading Israeli Clinical Site to Its Ongoing Clinical Trial for Alcohol Use Disorder
GlobeNewswire
·
June 23, 2025
Vancouver, Canada, June 23, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
Dr Ashleys Limited and Impact BioMedical Inc. Announce Strategic Merger
GlobeNewswire
·
June 23, 2025
A Strategic Move to Accelerate Market Reach for Innovative Pharmaceutical Patents on June 23, 2025 NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Dr Ashleys Limited, a Hong Kong based global pharmaceutical company (“Dr Ashleys”), and Impact BioMedical Inc. (“ …
Woodbridge Announces Sale of Custom Chemical Solutions, LLC to AAVIN Private Equity
GlobeNewswire
·
June 23, 2025
NEW HAVEN, Conn., June 23, 2025 (GLOBE NEWSWIRE) -- Woodbridge, a global mergers and acquisitions firm and a Mariner Company, is pleased to announce the acquisition of its client, Custom Chemical Solutions, LLC, by AAVIN Private Equity. Custom Chemical …
Fractyl Health Reports Positive 3-Month REVEAL-1 Cohort Data Showing Revita® Sustained Weight Loss After GLP-1 Discontinuation, Supporting its Potential as a First-in-Class Weight Maintenance Therapy
GlobeNewswire
·
June 23, 2025
12 of 13 participants maintained or lost weight at 3 months, with 6 of 13 losing additional weight after stopping GLP-1 therapy and undergoing Revita procedure Median weight remained stable through 3 months (0.46% / ~ 1 pound weight change within the …
Fractyl Health Presents New Data at the American Diabetes Association’s 85th Scientific Sessions Demonstrating its Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Platform Prevents Obesity and Type 2 Diabetes in Preclinical Models
GlobeNewswire
·
June 23, 2025
New findings demonstrated that a single dose of Rejuva was well tolerated in healthy animals, with no evidence of toxicity Rejuva-treated healthy animals exposed to a high fat diet were protected from weight gain and hyperglycemia Data reinforce …
Palvella Therapeutics Completes Enrollment in Phase 3 SELVA Trial of QTORIN™ Rapamycin for Microcystic Lymphatic Malformations, Exceeding Enrollment Target by Over 25%
GlobeNewswire
·
June 23, 2025
Enrollment of 51 subjects highlights significant unmet need in this serious, lifelong genetic disease which currently has no FDA-approved therapies Top-line data expected in the first quarter of 2026 WAYNE, Pa., June 23, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: …
NETCLASS TECHNOLOGY INC and Nanyang Institute of Social Sciences Join Forces to Explore New Paths in Smart Education
GlobeNewswire
·
June 23, 2025
SHANGHAI and HONG KONG, June 23, 2025 (GLOBE NEWSWIRE) -- NETCLASS Technology INC (Nasdaq: NTCL; the “Company” or “NetClass”), a leading B2B smart education IT solutions provider with offices in Shanghai, Hong Kong, Singapore and Tokyo, is pleased to …
CorMedix inc. Announces Customer Implementation
GlobeNewswire
·
June 23, 2025
BERKELEY HEIGHTS, N.J., June 23, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announces an update …
Carisma Therapeutics and OrthoCellix Enter into Definitive Merger Agreement to Create Company Focused on Regenerative Cell Therapies for Orthopedic Diseases
GlobeNewswire
·
June 23, 2025
Proposed reverse merger with OrthoCellix, a wholly-owned subsidiary of Ocugen, to create Nasdaq-listed, late clinical-stage regenerative cell therapy company with a first-in-class technology platform, focused on orthopedic diseases OrthoCellix is …
Alterity Therapeutics to Provide Corporate Update in Fireside Chat
GlobeNewswire
·
June 23, 2025
MELBOURNE, Australia and SAN FRANCISCO, June 23, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative …
Illuccix Approved in U.S. for Patient Selection for Pre-Taxane RLT
GlobeNewswire
·
June 23, 2025
MELBOURNE, Australia and INDIANAPOLIS, June 23, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces that the United States (U.S.) Food and Drug Administration (FDA) has approved a label …
Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina
GlobeNewswire
·
June 23, 2025
Up To $425 Million In Total Proceeds Inclusive of Near-term Milestone Payments; $350 Million In Upfront Cash Retains Strategic Upside with Illumina Protein Prep Royalty Stream and Rights to Single SOMAmer Reagent Business Simplifies Operating …
USA Rare Earth Bolsters Global Sales Effort with Appointment of Ron Fogarty as Vice President of Sales
GlobeNewswire
·
June 23, 2025
STILLWATER, Okla., June 23, 2025 (GLOBE NEWSWIRE) -- USA Rare Earth, Inc. (Nasdaq: USAR) (USAR or the Company), today announced the appointment of Ron Fogarty as Vice President of Sales. Mr. Fogarty will lead global sales efforts in support of the Company’ …
ArriVent Announces Positive Interim Firmonertinib Monotherapy Data From Global Phase 1b Study in EGFR PACC Mutant Non-Small Cell Lung Cancer and Plans to Advance into a Global Pivotal Study
GlobeNewswire
·
June 23, 2025
16.0 months median progression free survival (mPFS) with firmonertinib 240 mg by blinded independent central review (BICR) in first-line patients Robust central nervous system (CNS) activity; 41% (7/17) confirmed complete response (CR) and 53% confirmed …
Avalo Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire
·
June 23, 2025
WAYNE, Pa., June 23, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment of immune dysregulation, today announced that management will participate in the following investor …
Sono-Tek Receives $1.12 Million Order from Global Medical Diagnostics Company for High-Volume Coating Platform
GlobeNewswire
·
June 23, 2025
MILTON, N.Y., June 23, 2025 (GLOBE NEWSWIRE) -- Sono-Tek Corporation (Nasdaq: SOTK), a leading developer of ultrasonic precision coating systems, today announced that it has received a $1.12 million order from a long-standing customer in the medical …
OTC Markets Group Welcomes Torex Gold Resources Inc. to OTCQX
GlobeNewswire
·
June 23, 2025
NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Torex Gold Resources Inc. (TSX: TXG; OTCQX: TORXF), an intermediate gold …